Hyve Solutions Corporation, a wholly owned subsidiary of TD SYNNEX Corporation (NYSE:SNX) and a leading provider of hyperscale digital infrastructures, today announced the integration of Intel® Xeon® 6 processors into Hyve-designed motherboards and systems. This collaboration with Intel marks a significant step forward in meeting the diverse performance and efficiency requirements of modern computing environments, from high-performance AI applications to exceptional efficiency and cloud scalability.
Turning Point Therapeutics Provides Regulatory Update For Repotrectinib For The Treatment Of ROS1+ Advanced NSCLC
Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for cancer treatment, today announced receipt of positive feedback from the
